Results 41 to 50 of about 30,985 (250)

Measurement of cholesterol synthesis in kinetically defined pools using fecal steroid analysis and double labeling technique in man1

open access: yesJournal of Lipid Research, 1977
The purpose of the study was to develop a kinetic method for measurement of different parameters of cholesterol metabolism in man using labeled cholesterol precursors that could initially be incorporated even into the slowly exchangeable cholesterol pool.
M Kekki, T A Miettinen, B Wahlström
doaj   +1 more source

Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy

open access: yesFrontiers in Oncology, 2020
Recently, targeting metabolic reprogramming has emerged as a potential therapeutic approach for fighting cancer. Sterol regulatory element binding protein-2 (SREBP-2), a basic helix-loop-helix leucine zipper transcription factor, mainly regulates genes ...
Linyuan Xue   +8 more
doaj   +1 more source

Mevalonate Dependence and Apoptosis in Blood Cancers

open access: yes, 2021
There is a resurgence of interest in understanding the role of the mevalonate pathway in cancer. The on-target anti-cancer effects of the clinical mevalonate inhibitors, statins, are plentiful and diverse across several cancer models.
Juarez, Dennis
core   +1 more source

Immunomodulatory effects of atorvastatin on peripheral blood mononuclear cells infected with Mycobacterium tuberculosis

open access: yesFrontiers in Immunology
BackgroundTuberculosis (TB) remains a major global health threat, contributing substantially to high morbidity and mortality rates. This underscores the urgent need for more effective interventions. Recent studies highlight the potential of host-directed
Solima Sabeel   +16 more
doaj   +1 more source

p53 regulates Mevalonate Metabolic pathway

open access: yes, 2014
2012-2013The mevalonate pathway is an important metabolic pathway implicated in multiple aspects of tumorigenesis. In this study, I provided evidences about genetic and pharmacologic perturbation of p53, which directly influenced expression of mevalonate
D'Alessandro, Alba
core   +1 more source

A cofactor-promiscuous HMGR from the Lyme disease pathogen illuminates diversity in bacterial isoprenoid biosynthesis. [PDF]

open access: yesProtein Sci
Abstract The Lyme disease pathogen Borrelia burgdorferi contains a highly reduced genome lacking many primary metabolic pathways. However, B. burgdorferi retains the mevalonate pathway that synthesizes isopentenyl pyrophosphate (IPP), the precursor to the peptidoglycan carrier lipid.
Paddy IA   +7 more
europepmc   +2 more sources

Biosynthesis of Δ7-cholesten-3Β-ol, Δ5,7-cholestadien-3Β-ol, and Δ5-cholesten-3Β-ol by guinea pig intestinal mucosa in vitro

open access: yesJournal of Lipid Research, 1966
Methods were developed for the separation and determination of the various 27-carbon sterols of intestinal mucosa by means of thin-layer chromatography.
Robert K. Ockner, Leonard Laster
doaj   +1 more source

Activation of the plant mevalonate pathway by extracellular ATP

open access: yesNature Communications, 2022
Products of the mevalonate pathway support plant development. Here the authors show that the extracellular ATP receptor P2K1 phosphorylates mevalonate kinase and this affects the mevalonate pathway.
Sung-Hwan Cho   +9 more
doaj   +1 more source

(R)-Mevalonate 3-Phosphate Is an Intermediate of the Mevalonate Pathway in Thermoplasma acidophilum [PDF]

open access: yesJournal of Biological Chemistry, 2014
The lack of a few conserved enzymes in the classical mevalonate pathway and the widespread existence of isopentenyl phosphate kinase suggest the presence of a partly modified mevalonate pathway in most archaea and in some bacteria. In the pathway, (R)-mevalonate 5-phosphate is thought to be metabolized to isopentenyl diphosphate via isopentenyl ...
Yasuhiro, Azami   +5 more
openaire   +2 more sources

Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2006
Mevalonic aciduria (MVA) and hyperimmunoglobulinemia D syndrome (HIDS) represent the two ends of a clinical spectrum of disease caused by deficiency of mevalonate kinase (MVK), the first committed enzyme of cholesterol biosynthesis. At least 30 patients with MVA and 180 patients with HIDS have been reported worldwide.
Hoffmann Georg F, Haas Dorothea
openaire   +3 more sources

Home - About - Disclaimer - Privacy